It's looking good.
Gross margin = 47.9%
Operating margin = 41.6%
Pre-tax margin = 41.2%
Net Profit margin = 39.8%
PER at SP of A$0.88 = 2.9x
Sales growth since FY14 = 45.3%
Costs/t = US$61
Debt is down to US$8m from US$9.3 at end of FY14
Cash has moved up to US$13.6m
Annualised Ev/OPCF is just 1.9x
Annualised EPS is currently at A$0.24
EPS growth is 62%
Earnings yield (EBIT/Ev) is 19%
Surely, just a matter of time before the market gets around to a re-rating.
CPDLC
- Forums
- ASX - By Stock
- X64
- Ann: Highlights of Half year Results December 2014
Ann: Highlights of Half year Results December 2014, page-4
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add X64 (ASX) to my watchlist
(20min delay)
|
|||||
Last
57.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $129.8M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
X64 (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online